Table 1 Clinical characteristics of patients with active CD and normal participants.
Clinical Characteristics | Normal participants | CD |
|---|---|---|
Number | 43 | 43 |
Gender (Male/Female) | 28/15 | 30/13 |
Age, ya | 46.65 ± 13.28 | 31.5 ± 11.66 |
Disease duration, ya | - | 2.99 ± 3.61 |
Origin of surgical specimens, n (%) | - | 28 (65) |
Ileum | - | 16 |
Colon | - | 12 |
Disease location, n (%) | ||
L1 (ileal) | - | 18 (42) |
L2 (colonic) | - | 12 (28) |
L3 (ileocolonic) | - | 13 (30) |
L4 (isolated upper disease) | - | 0 |
Disease behavior, n (%) | ||
B1(non-stricturing, non-penetrating) | - | 23 (53) |
B2 (stricturing) | - | 12 (28) |
B3 (penetrating) | - | 8 (19) |
Perianal complications, n (%) | - | 12 (28) |
Smoking history, n (%) | ||
Never | 32 (74) | 38 (88) |
Former | 3 (7) | 0 |
Current | 8 (19) | 5 (12) |
Medication, n (%) | ||
Mesalazine | - | 13 (30) |
Corticosteroids | - | 4 (9) |
Immunosuppressants | - | 6 (14) |
Infliximab | - | 5 (12) |
